ClearBridge Investments shares Q2 strategy shifts toward value and defense. See how disciplined stock picks aim to balance ...

Harmony Biosciences Holdings Inc (NASDAQ:HRMY) is set to release its Q2 2025 earnings on Aug 5, 2025. The consensus estimate for Q2 2025 revenue is $204.45 million, and the earnings are expected to ...

Arab Finance: Consumer gold purchases in several Arab markets saw a noticeable decline in the second quarter (Q2) of 2025, ...

The strong second-quarter result prompted management to increase its full-year revenue forecast for 2025 to $871.5 million ...

Management described loan origination targets as repayment-dependent, acknowledging portfolio growth and dividend stability could be at risk if anticipated repayments do not materialize as projected, ...

Fresenius Medical Care (NYSE:FMS) on Tuesday announced second-quarter 2025 revenue of €4,792 million, aligning closely with ...